Rood, Jennifer E. http://orcid.org/0000-0002-9489-0731
Maartens, Aidan
Hupalowska, Anna
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Funding for this research was provided by:
Wellcome Trust (206194, 108413/A/15/D)
Article History
Received: 24 August 2022
Accepted: 24 October 2022
First Online: 8 December 2022
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 July 2020, was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Asimov and Neogene Therapeutics. From 1 August 2020, A.R. is an employee of Genentech and has equity in Roche. A.R. is a named inventor on multiple patents related to single-cell and spatial genomics filed by or issued to the Broad Institute. J.E.R. and A.H. are employees of Genentech and have equity in Roche. In the past three years, S.A.T. has consulted or been a member of scientific advisory boards at Roche, Genentech, Biogen, GlaxoSmithKline, Qiagen and ForeSite Labs, and is an equity holder of Transition Bio.
Free to read: This content has been made available to all.